Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody production without animals.

B M Stadler1

  • 1Institute of Immunology and Allergology, Inselhospital, University of Bern, Switzerland.

Developments in Biological Standardization
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins.

European cells & materials·2014
Same author

Increased level of antibodies cross-reacting with Ves v 5 and CRISP-2 in MAR-positive patients.

International archives of allergy and immunology·2012
Same author

Cross-reactions vs co-sensitization evaluated by in silico motifs and in vitro IgE microarray testing.

Allergy·2011
Same author

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.

Allergy·2011
Same author

Monomeric and dimeric IgG fractions show differential reactivity against pathogen-derived antigens.

Scandinavian journal of immunology·2011
Same author

Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.

Allergy·2011
Same journal

International challenges and public policy issues.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000
Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000
Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000
Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000
See all related articles

New gene technology enables antibody generation without animal immunization. This approach allows for the creation of synthetic antibody libraries, offering vast potential for diagnostic and therapeutic applications.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Traditional antibody generation relies on animal or human immunization.
  • Cloning the human antibody repertoire and utilizing phage display technology have advanced antibody discovery.
  • Existing methods often require B-cells from immunized sources.

Purpose of the Study:

  • To explore novel methods for generating antibodies independent of animal immunization.
  • To investigate the potential of synthetic antibody libraries for discovering new specificities.
  • To highlight advancements in antibody gene technology for diagnostic and therapeutic use.

Main Methods:

  • Cloning of the human antibody repertoire.
  • Application of phage display technology for library screening.

Related Experiment Videos

  • Development and utilization of synthetic antibody libraries.
  • Main Results:

    • Phage display enables identification of rare specificities in large libraries (10^8 to 10^10).
    • Synthetic antibody libraries offer complexity comparable to natural mammalian immune systems.
    • Antibodies can now be generated entirely independently of animal immunization.

    Conclusions:

    • Gene technology advancements allow for animal-free antibody production.
    • Synthetic and immune libraries provide powerful tools for antibody discovery.
    • These methods hold significant promise for future diagnostic and therapeutic antibody development.